A Randomized Phase II Presurgical Trial of Weekly Low-Dose Tamoxifen Versus Raloxifene Versus Placebo in Premenopausal Women With Estrogen Receptor-Positive Breast Cancer
Breast Cancer Research - United Kingdom
doi 10.1186/bcr3439
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2013
Authors
Publisher
Springer Science and Business Media LLC